Mercator Medical S.A. (WSE:MRC)
Poland · Delayed Price · Currency is PLN 59.20
-0.40 (-0.67%)
Oct 15, 2026, 3:51 PM CET
Mercator Medical Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 620.43 | 574.18 | 542.49 | 469.06 | 542.51 | 1,727 |
Other Revenue | 4.75 | 0.26 | 0.21 | 0.16 | 0.25 | 1.86 |
| 625.18 | 574.43 | 542.69 | 469.23 | 542.77 | 1,729 | |
Revenue Growth | 7.82% | 5.85% | 15.66% | -13.55% | -68.61% | -5.79% |
Cost of Revenue | 399.87 | 411.64 | 401.58 | 366.4 | 445.94 | 1,084 |
Gross Profit | 225.31 | 162.79 | 141.11 | 102.83 | 96.82 | 644.96 |
Selling, General & Admin | 130.88 | 136.75 | 132.78 | 135.84 | 144.94 | 147.73 |
Other Operating Expenses | 18.25 | 12.44 | 8.53 | 18.39 | 0.97 | 14.96 |
Operating Expenses | 179.86 | 177.97 | 164.61 | 176.35 | 171.57 | 182 |
Operating Income | 45.45 | -15.18 | -23.5 | -73.52 | -74.75 | 462.96 |
Interest Expense | -1.92 | -0.48 | -0.33 | -0.83 | -0.33 | -0.12 |
Interest & Investment Income | 7.97 | 15.89 | 21.44 | 23.68 | 14.06 | 0.84 |
Earnings From Equity Investments | 0.2 | -0.04 | - | - | - | 2.28 |
Currency Exchange Gain (Loss) | -5.57 | 13.97 | -13 | 40.09 | -17.22 | 19.02 |
Other Non Operating Income (Expenses) | 17.88 | 5.75 | -5.98 | 8.05 | 24.21 | -1.12 |
EBT Excluding Unusual Items | 64.02 | 19.89 | -21.37 | -2.53 | -54.03 | 483.86 |
Gain (Loss) on Sale of Investments | 0.04 | 0.42 | 3.12 | 14.53 | -4.93 | -6.38 |
Gain (Loss) on Sale of Assets | 5.15 | 5.15 | -1.65 | -0.37 | 0.47 | 0.1 |
Asset Writedown | 2.64 | 3.12 | 55.54 | -15.3 | -127.52 | - |
Legal Settlements | -0.05 | -0.19 | -0.2 | -0.12 | -0.21 | -0.35 |
Pretax Income | 71.79 | 28.4 | 35.44 | -3.79 | -186.22 | 477.23 |
Income Tax Expense | 5.8 | -0.95 | -7.97 | 19.04 | 4.57 | 32.37 |
Earnings From Continuing Operations | 65.99 | 29.34 | 43.41 | -22.84 | -190.79 | 444.85 |
Minority Interest in Earnings | 0.86 | -0.75 | 1.22 | 3.16 | 1.16 | 2.01 |
Net Income | 66.86 | 28.59 | 44.63 | -19.68 | -189.62 | 446.87 |
Net Income to Common | 66.86 | 28.59 | 44.63 | -19.68 | -189.62 | 446.87 |
Net Income Growth | 12.21% | -35.94% | - | - | - | -51.96% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 10 | 10 | 10 |
Shares Change | -1.70% | -1.80% | -2.02% | -1.91% | -3.47% | -3.88% |
EPS (Basic) | 7.30 | 3.10 | 4.75 | -2.05 | -19.41 | 44.15 |
EPS (Diluted) | 7.30 | 3.10 | 4.75 | -2.05 | -19.41 | 44.15 |
EPS Growth | 14.25% | -34.74% | - | - | - | -50.02% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.72 | -13.45 | -84.75 | -39.15 | -68.86 | 326.25 |
Free Cash Flow Per Share | 0.19 | -1.46 | -9.03 | -4.08 | -7.05 | 32.23 |
Dividend Per Share | 0.670 | 0.670 | 1.610 | - | - | - |
Dividend Growth | -58.38% | -58.38% | - | - | - | - |
Gross Margin | 36.04% | 28.34% | 26.00% | 21.91% | 17.84% | 37.30% |
Operating Margin | 7.27% | -2.64% | -4.33% | -15.67% | -13.77% | 26.77% |
Profit Margin | 10.69% | 4.98% | 8.22% | -4.19% | -34.94% | 25.84% |
Free Cash Flow Margin | 0.27% | -2.34% | -15.62% | -8.34% | -12.69% | 18.87% |
EBITDA | 73.79 | 8.81 | -4.71 | -53.87 | -50.74 | 481.34 |
EBITDA Margin | 11.80% | 1.53% | -0.87% | -11.48% | -9.35% | 27.84% |
D&A For EBITDA | 28.34 | 23.99 | 18.79 | 19.66 | 24.01 | 18.38 |
EBIT | 45.45 | -15.18 | -23.5 | -73.52 | -74.75 | 462.96 |
EBIT Margin | 7.27% | -2.64% | -4.33% | -15.67% | -13.77% | 26.77% |
Effective Tax Rate | 8.08% | - | - | - | - | 6.78% |
Revenue as Reported | 635.14 | 587.22 | 613.75 | 514.69 | 605.48 | 1,733 |